NFDHA
Nonafluoro-3,6-dioxaheptanoic acid
2,2-difluoro-2-[1,1,2,2-tetrafluoro-2-(trifluoromethoxy)ethoxy]acetic acid
A short-chain perfluoroether carboxylic acid; toxicology dataset is limited but assumed PFAS-class persistent. Low-prevalence UCMR 5 analyte detected in 14 U.S. public water systems serving 376K people at very low ppt levels.
Primary concern: Immune and liver toxicity
Affected organ systems
Health effects
Exposure routes
Vulnerable populations
Overview
Nonafluoro-3,6-dioxaheptanoic acid (NFDHA) is a short-chain perfluoroether carboxylic acid built from a 2-carbon perfluoroalkyl tail, two ether oxygens, a perfluoromethyl head, and a terminal carboxylic acid (C5HF9O4, MW 296). It is structurally smaller than either of its UCMR 5 perfluoroether siblings — HFPO-DA (GenX, MW 330) and ADONA (MW 378). The compound has been used and studied primarily as an industrial fluorochemical processing intermediate and as a known biotransformation product of larger perfluoroether-ether precursors. Its independent commercial use is small, and the published toxicology dataset is correspondingly thin. UCMR 5 places NFDHA among the lowest-occurrence analytes in the program: detected in only 14 U.S. public water systems across four states (New York, Rhode Island, Texas, and Minnesota), serving roughly 376,000 people, with even the highest measured concentration (0.00394 ppb / 3.94 ppt at Clute, Texas) sitting well below NFDHA's own UCMR 5 Minimum Reporting Level of 20 ppt — every reported NFDHA value is an EPA-J-flagged estimate below the formal quantitation limit.
Pollution sources
Sources
Documented sources of NFDHA in U.S. drinking water are limited. Two source patterns are consistent with the observed geography: (1) industrial discharges and atmospheric deposition from fluoropolymer or specialty-chemical manufacturing — likely explaining the Clute / Richwood / Hemphill clusters in coastal Texas where the petrochemical and fluorochemical industries are concentrated; and (2) PFAS-precursor degradation in groundwater at known multi-PFAS impact sites — likely explaining the Rhode Island Newport-area detections (Naval Station Newport co-occurs with documented AFFF impact) and the Long Island, NY detections (regional groundwater PFAS plume). Because NFDHA can arise as a transformation product of larger perfluoroether ethers, its appearance can also signal the presence of unmeasured upstream precursors in the same source water.
Health risks
There is no NFDHA-specific Reference Dose, Health Reference Level, or carcinogen classification from EPA, IARC, or NTP. Risk assessment is therefore class-extrapolated from the better-studied perfluoroether carboxylic acids (HFPO-DA / GenX, ADONA) and broader PFAS: the carbon-fluorine and ether-oxygen backbone is environmentally and biologically persistent, and the structural similarity to HFPO-DA implies likely hepatotoxic and immunotoxic potential at sufficient exposures. Pharmacokinetic data in humans is essentially absent — no defensible serum half-life has been published — so EPA included NFDHA in UCMR 5 precisely to build the occurrence dataset that future toxicology work will need.
Effective treatments
Does not remove
NSF certifications
Water treatment
NFDHA is removed by the same processes that handle other short-chain perfluoroether acids: granular activated carbon (GAC), anion exchange resin, and high-pressure membranes (reverse osmosis, nanofiltration). The short perfluorinated chain and small molecular weight mean GAC adsorption is weaker than for long-chain PFAS like PFOA or PFOS — utilities sizing GAC for NFDHA should expect earlier breakthrough and shorter media life relative to legacy PFAS, mirroring the operational pattern observed with HFPO-DA and ADONA. Conventional treatment processes — coagulation, sand filtration, disinfection, UV, and ozonation — do not remove it. Boiling concentrates rather than removes it. NSF/ANSI 53 and NSF P473 certify point-of-use filters for general PFAS reduction; NSF/ANSI 58 covers RO systems.
Gallery

Related contaminants
Chemistry + classification data sourced from public databases (PubChem, EPA CompTox, IARC monographs); 3D molecular models from 3d.nih.gov where available.